MELPHALAN HYDROCHLORIDE

MELPHALAN HYDROCHLORIDE was reported 25290 times

MELPHALAN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHOROIDAL DYSTROPHY 29 0.6042
1 MENINGOMYELITIS HERPES 15 0.4688
2 PROTOTHECOSIS 37 0.3936
3 CHORIORETINAL ATROPHY 67 0.3237
4 REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA 27 0.2647
5 MUCOEPIDERMOID CARCINOMA OF SALIVARY GLAND 15 0.2542
6 ENGRAFTMENT SYNDROME 142 0.2403
7 PRE-ENGRAFTMENT IMMUNE REACTION 19 0.2375
8 CHOROIDAL INFARCTION 28 0.2333
9 RETINOBLASTOMA 25 0.2294
10 IRIS ATROPHY 42 0.2029
11 ENGRAFT FAILURE 58 0.2021
12 CLONAL HAEMATOPOIESIS 15 0.1948
13 MALIGNANT TRANSFORMATION 85 0.1893
14 NEUROBLASTOMA RECURRENT 36 0.1773
15 BLOOD STEM CELL TRANSPLANT FAILURE 37 0.1721
16 IDIOPATHIC PNEUMONIA SYNDROME 51 0.1711
17 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 20 0.1639
18 POEMS SYNDROME 17 0.1619
19 ADENOVIRUS REACTIVATION 22 0.1528
20 PNEUMONIA ADENOVIRAL 30 0.1515
21 ADENOVIRAL HEPATITIS 35 0.1489
22 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 28 0.1474
23 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 206 0.1458
24 GASTROENTERITIS ADENOVIRUS 22 0.1401
25 LIGHT CHAIN DISEASE 19 0.1310
26 RETINAL DEPIGMENTATION 40 0.1307
27 ACUTE GRAFT VERSUS HOST DISEASE 580 0.1266
28 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 350 0.1265
29 ADENOVIRUS INFECTION 354 0.1219
30 IRIS NEOVASCULARISATION 15 0.1200
31 HUMAN HERPESVIRUS 6 ENCEPHALITIS 33 0.1162
32 GRAFT VERSUS HOST DISEASE IN INTESTINE 15 0.1154
33 VENOOCCLUSIVE LIVER DISEASE 554 0.1121
34 RETINAL PIGMENT EPITHELIOPATHY 48 0.1111
35 ADENOVIRAL HAEMORRHAGIC CYSTITIS 23 0.1106
36 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 79 0.1099
37 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 37 0.1054
38 VENOOCCLUSIVE DISEASE 263 0.1049
39 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 95 0.1026
40 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 135 0.1025
41 CHRONIC GRAFT VERSUS HOST DISEASE 367 0.1015
42 CYSTITIS VIRAL 38 0.0992
43 VIRAL HAEMORRHAGIC CYSTITIS 70 0.0983
44 EYE EXCISION 20 0.0976
45 GRAFT VERSUS HOST DISEASE IN SKIN 209 0.0948
46 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 199 0.0934
47 CHORIORETINAL DISORDER 18 0.0914
48 AUTOIMMUNE NEUTROPENIA 26 0.0900
49 PLASMACYTOSIS 17 0.0890
50 MANTLE CELL LYMPHOMA RECURRENT 38 0.0874
51 EXTRAOCULAR MUSCLE DISORDER 27 0.0836
52 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 26 0.0831
53 PLASMA CELL MYELOMA REFRACTORY 110 0.0822
54 HUMAN HERPESVIRUS 6 INFECTION 150 0.0793
55 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 19 0.0776
56 EPSTEIN-BARR VIRAEMIA 86 0.0775
57 B-CELL TYPE ACUTE LEUKAEMIA 54 0.0736
58 VIRAEMIA 99 0.0714
59 GRAFT VERSUS HOST DISEASE 509 0.0707
60 CENTRAL HYPOTHYROIDISM 23 0.0695
61 NASAL ABSCESS 16 0.0693
62 BONE MARROW TRANSPLANT REJECTION 15 0.0682
63 B-CELL LYMPHOMA RECURRENT 37 0.0681
64 OSTEOSARCOMA 26 0.0675
65 BONE DEBRIDEMENT 32 0.0663
66 CYTOMEGALOVIRUS INFECTION REACTIVATION 287 0.0649
67 APOPTOSIS 20 0.0647
68 B PRECURSOR TYPE ACUTE LEUKAEMIA 25 0.0644
69 UREAPLASMA INFECTION 26 0.0637
70 POLYCHROMASIA 19 0.0633
71 PLASMA CELL MYELOMA RECURRENT 204 0.0627
72 CEREBRAL TOXOPLASMOSIS 58 0.0621
73 GRAFT VERSUS HOST DISEASE IN LIVER 44 0.0615
74 STEM CELL TRANSPLANT 151 0.0604
75 PLASMA CELL LEUKAEMIA 36 0.0600
76 JC VIRUS INFECTION 94 0.0587
77 COMPLICATIONS OF BONE MARROW TRANSPLANT 21 0.0582
78 MORGANELLA INFECTION 17 0.0580
79 WOUND DEBRIDEMENT 24 0.0574
80 PRIMARY SEQUESTRUM 51 0.0563
81 GASTROINTESTINAL FUNGAL INFECTION 28 0.0544
82 BK VIRUS INFECTION 178 0.0527
83 MONOCLONAL IMMUNOGLOBULIN INCREASED 15 0.0524
84 MYELODYSPLASTIC SYNDROME 722 0.0499
85 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 18 0.0495
86 MUCOSAL INFLAMMATION 1281 0.0489
87 THROMBOTIC MICROANGIOPATHY 472 0.0484
88 PLASMACYTOMA 88 0.0472
89 IRIS ADHESIONS 24 0.0468
90 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 237 0.0465
91 TRANSPLANT FAILURE 114 0.0465
92 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 39 0.0463
93 OSTEOLYSIS 94 0.0459
94 GASTROINTESTINAL MUCOSAL DISORDER 30 0.0458
95 NEUTROPENIC COLITIS 94 0.0454
96 ACUTE LYMPHOCYTIC LEUKAEMIA 128 0.0452
97 ENTEROCOCCAL BACTERAEMIA 47 0.0443
98 PARAINFLUENZAE VIRUS INFECTION 67 0.0440
99 ENTEROCOCCAL SEPSIS 35 0.0432
100 TRANSPLANTATION COMPLICATION 18 0.0429
101 KLEBSIELLA BACTERAEMIA 40 0.0421
102 VITREOUS HAEMORRHAGE 116 0.0419
103 CYSTITIS HAEMORRHAGIC 166 0.0411
104 HUMAN HERPESVIRUS 8 INFECTION 25 0.0411
105 PNEUMONIA CYTOMEGALOVIRAL 79 0.0406
106 CYTOMEGALOVIRUS TEST POSITIVE 71 0.0398
107 GRAFT VERSUS HOST DISEASE IN LUNG 19 0.0397
108 HUMAN POLYOMAVIRUS INFECTION 21 0.0395
109 METAPNEUMOVIRUS INFECTION 31 0.0395
110 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 87 0.0394
111 SEQUESTRECTOMY 26 0.0390
112 EPSTEIN-BARR VIRUS INFECTION 241 0.0385
113 METASTATIC LYMPHOMA 15 0.0384
114 ASEPTIC NECROSIS BONE 30 0.0384
115 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 67 0.0379
116 FUSARIUM INFECTION 26 0.0371
117 PULMONARY VENO-OCCLUSIVE DISEASE 26 0.0371
118 SYSTEMIC MYCOSIS 43 0.0368
119 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 24 0.0366
120 METASTASES TO BONE MARROW 18 0.0360
121 CYTOMEGALOVIRUS VIRAEMIA 160 0.0359
122 MONOCLONAL GAMMOPATHY 22 0.0351
123 KLEBSIELLA SEPSIS 39 0.0346
124 ACTINOMYCOSIS 33 0.0344
125 LENTICULAR OPACITIES 15 0.0343
126 ENCEPHALITIS CYTOMEGALOVIRUS 15 0.0342
127 ACUTE MYELOID LEUKAEMIA 534 0.0342
128 INFECTION REACTIVATION 39 0.0341
129 SCEDOSPORIUM INFECTION 24 0.0340
130 VARICELLA ZOSTER VIRUS INFECTION 70 0.0337
131 APLASIA 66 0.0337
132 SINUS POLYP 19 0.0329
133 PLASMA CELL MYELOMA 1286 0.0329
134 BACTERIAL SEPSIS 106 0.0325
135 IIIRD NERVE PARALYSIS 26 0.0321
136 ENCEPHALITIS VIRAL 39 0.0320
137 SECOND PRIMARY MALIGNANCY 266 0.0319
138 PREMATURE MENOPAUSE 29 0.0314
139 ROTAVIRUS INFECTION 18 0.0312
140 MINIMAL RESIDUAL DISEASE 15 0.0311
141 PNEUMOCOCCAL SEPSIS 20 0.0304
142 CHRONIC MYELOMONOCYTIC LEUKAEMIA 20 0.0303
143 CANDIDA SEPSIS 27 0.0301
144 TOXOPLASMOSIS 32 0.0296
145 AMYLOIDOSIS 51 0.0295
146 RETINAL ISCHAEMIA 18 0.0295
147 CYTOMEGALOVIRUS INFECTION 480 0.0289
148 HERPES ZOSTER DISSEMINATED 23 0.0286
149 CRYPTOSPORIDIOSIS INFECTION 15 0.0286
150 FUNGAEMIA 45 0.0286
151 PULMONARY MYCOSIS 22 0.0282
152 RETINAL TOXICITY 29 0.0282
153 OCULAR VASCULAR DISORDER 23 0.0279
154 SYSTEMIC CANDIDA 70 0.0279
155 AORTIC CALCIFICATION 16 0.0275
156 ABDOMINAL COMPARTMENT SYNDROME 17 0.0267
157 OBLITERATIVE BRONCHIOLITIS 35 0.0267
158 CYTOMEGALOVIRUS CHORIORETINITIS 52 0.0266
159 HEPATITIS E 42 0.0266
160 MONOCLONAL IMMUNOGLOBULIN PRESENT 20 0.0263
161 MULTIPLE MYELOMA 119 0.0255
162 ESCHERICHIA BACTERAEMIA 59 0.0251
163 STENOTROPHOMONAS INFECTION 34 0.0251
164 FOLLICULAR LYMPHOMA 22 0.0250
165 HYPOGAMMAGLOBULINAEMIA 164 0.0249
166 ACUTE MYELOID LEUKAEMIA RECURRENT 53 0.0247
167 STAPHYLOCOCCAL BACTERAEMIA 107 0.0246
168 OSTEOSCLEROSIS 38 0.0241
169 BONE LESION 87 0.0241
170 STREPTOCOCCAL BACTERAEMIA 26 0.0239
171 RETINAL DEGENERATION 31 0.0238
172 BONE SWELLING 23 0.0238
173 MANTLE CELL LYMPHOMA 36 0.0236
174 ENTEROCOCCAL INFECTION 114 0.0236
175 ENTEROVIRUS INFECTION 20 0.0231
176 VERTEBRAL FORAMINAL STENOSIS 19 0.0231
177 PNEUMONIA FUNGAL 91 0.0230
178 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 188 0.0228
179 STAPHYLOCOCCAL SEPSIS 110 0.0223
180 CYTOMEGALOVIRUS ENTEROCOLITIS 17 0.0221
181 BRONCHOPULMONARY ASPERGILLOSIS 171 0.0220
182 HAEMATOTOXICITY 209 0.0220
183 HEPATITIS B REACTIVATION 69 0.0217
184 BACTERAEMIA 258 0.0217
185 POLYNEUROPATHY 258 0.0215
186 CYTOPENIA 263 0.0215
187 GASTROINTESTINAL TOXICITY 103 0.0214
188 MICROANGIOPATHY 20 0.0213
189 CYTOGENETIC ABNORMALITY 24 0.0213
190 PARVOVIRUS B19 INFECTION 19 0.0212
191 BONE MARROW TOXICITY 25 0.0211
192 INTERVERTEBRAL DISC SPACE NARROWING 17 0.0211
193 MUCOSAL EROSION 19 0.0209
194 FEBRILE NEUTROPENIA 1356 0.0204
195 ENDOCARDITIS BACTERIAL 16 0.0203
196 VITH NERVE PARALYSIS 23 0.0202
197 SINUSITIS FUNGAL 16 0.0200
198 ASPERGILLUS INFECTION 130 0.0198
199 ESCHERICHIA SEPSIS 57 0.0196
200 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 144 0.0192
201 DIARRHOEA INFECTIOUS 15 0.0190
202 MUCOUS MEMBRANE DISORDER 26 0.0190
203 EJECTION FRACTION ABNORMAL 23 0.0188
204 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 179 0.0187
205 PERIPHERAL SENSORIMOTOR NEUROPATHY 23 0.0183
206 ABSCESS JAW 19 0.0183
207 DISTURBANCE IN SOCIAL BEHAVIOUR 43 0.0182
208 CAPILLARY LEAK SYNDROME 37 0.0179
209 VASCULAR CALCIFICATION 19 0.0178
210 LEUKAEMIA RECURRENT 30 0.0177
211 GASTROINTESTINAL INFLAMMATION 139 0.0177
212 PNEUMONIA INFLUENZAL 21 0.0176
213 ADENOCARCINOMA OF COLON 33 0.0176
214 EXPOSED BONE IN JAW 38 0.0175
215 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 45 0.0174
216 CYTOMEGALOVIRUS COLITIS 40 0.0174
217 THERAPY PARTIAL RESPONDER 270 0.0173
218 ADENOCARCINOMA GASTRIC 16 0.0172
219 PSEUDOMONAL SEPSIS 30 0.0171
220 FEBRILE BONE MARROW APLASIA 72 0.0169
221 HISTIOCYTOSIS HAEMATOPHAGIC 50 0.0168
222 HAEMATOLOGICAL INFECTION 40 0.0163
223 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 15 0.0162
224 ACUTE LEUKAEMIA 26 0.0161
225 POLYOMAVIRUS VIRAEMIA 17 0.0160
226 AUTONOMIC NEUROPATHY 16 0.0158
227 RENAL TUBULAR INJURY 19 0.0156
228 PNEUMONIA STREPTOCOCCAL 17 0.0155
229 GASTROINTESTINAL WALL THICKENING 23 0.0154
230 DIFFUSE LARGE B-CELL LYMPHOMA 116 0.0150
231 BLOOD IMMUNOGLOBULIN G INCREASED 18 0.0148
232 TRANSITIONAL CELL CARCINOMA 19 0.0146
233 ACUTE PROMYELOCYTIC LEUKAEMIA 15 0.0146
234 ASPERGILLOSIS 19 0.0145
235 CARDIAC AMYLOIDOSIS 16 0.0145
236 MYCOBACTERIAL INFECTION 25 0.0145
237 FEBRILE INFECTION 17 0.0144
238 NEUTROPENIC SEPSIS 103 0.0144
239 DEVICE RELATED SEPSIS 29 0.0144
240 HYPOPERFUSION 15 0.0143
241 PERIPHERAL SENSORY NEUROPATHY 83 0.0142
242 CLOSTRIDIUM COLITIS 17 0.0140
243 PHARYNGEAL INFLAMMATION 17 0.0140
244 LYMPHOPROLIFERATIVE DISORDER 41 0.0139
245 RHINOVIRUS INFECTION 54 0.0139
246 PULMONARY TOXICITY 98 0.0138
247 KLEBSIELLA INFECTION 70 0.0138
248 NEUROLOGICAL DECOMPENSATION 32 0.0138
249 HAEMOLYTIC URAEMIC SYNDROME 32 0.0138
250 MULTI-ORGAN FAILURE 237 0.0137
251 MULTIPLE ORGAN DYSFUNCTION SYNDROME 385 0.0136
252 GASTROENTERITIS NOROVIRUS 18 0.0135
253 STREPTOCOCCAL SEPSIS 16 0.0135
254 MENINGITIS BACTERIAL 19 0.0133
255 PNEUMONIA PSEUDOMONAL 20 0.0130
256 KYPHOSIS 23 0.0130
257 PNEUMONIA PNEUMOCOCCAL 19 0.0128
258 CUTANEOUS T-CELL LYMPHOMA 16 0.0127
259 BLOOD CULTURE POSITIVE 38 0.0127
260 HYPERAMMONAEMIC ENCEPHALOPATHY 22 0.0126
261 APLASTIC ANAEMIA 66 0.0126
262 SOFT TISSUE INFECTION 23 0.0126
263 LUNG INFILTRATION 111 0.0126
264 PULMONARY HAEMORRHAGE 98 0.0125
265 EMBOLISM ARTERIAL 15 0.0125
266 OTOTOXICITY 23 0.0124
267 PANCYTOPENIA 690 0.0123
268 AUTOIMMUNE HAEMOLYTIC ANAEMIA 42 0.0122
269 ACUTE RESPIRATORY DISTRESS SYNDROME 216 0.0122
270 HEPATITIS B 73 0.0121
271 NEOPLASM RECURRENCE 41 0.0121
272 MASTICATION DISORDER 37 0.0121
273 KERATOPATHY 19 0.0120
274 ARTERIAL THROMBOSIS 23 0.0119
275 RETINAL ARTERY OCCLUSION 30 0.0119
276 BONE MARROW FAILURE 241 0.0118
277 OPTIC ATROPHY 19 0.0117
278 CLOSTRIDIUM DIFFICILE COLITIS 123 0.0116
279 NEOPLASM SKIN 18 0.0116
280 PNEUMATOSIS INTESTINALIS 33 0.0116
281 H1N1 INFLUENZA 16 0.0114
282 LYMPHOPENIA 156 0.0110
283 PSEUDOMONAS INFECTION 94 0.0110
284 LICHENOID KERATOSIS 25 0.0109
285 SEPTIC SHOCK 471 0.0108
286 CARDIOTOXICITY 95 0.0106
287 GENE MUTATION 21 0.0106
288 VENTRICULAR HYPOKINESIA 34 0.0106
289 ENTEROCOLITIS 61 0.0106
290 MYELOPATHY 20 0.0105
291 KIDNEY FIBROSIS 18 0.0104
292 SPONDYLOLISTHESIS 18 0.0104
293 ENTERITIS 66 0.0103
294 OSTEITIS 26 0.0103
295 SQUAMOUS CELL CARCINOMA OF SKIN 62 0.0103
296 THROMBOCYTOPENIA 1148 0.0103
297 HEPATOSPLENOMEGALY 26 0.0101
298 JUGULAR VEIN THROMBOSIS 18 0.0101
299 AORTIC ARTERIOSCLEROSIS 26 0.0101
300 NEPHROPATHY TOXIC 113 0.0101
301 PNEUMOCYSTIS JIROVECII PNEUMONIA 101 0.0100
302 EMBOLISM VENOUS 30 0.0099
303 ACUTE SINUSITIS 17 0.0098
304 ESCHERICHIA INFECTION 81 0.0098
305 ENCEPHALITIS 68 0.0098
306 NOCARDIOSIS 25 0.0098
307 CLOSTRIDIAL INFECTION 33 0.0097
308 LEUKOENCEPHALOPATHY 36 0.0097
309 TUMOUR LYSIS SYNDROME 84 0.0095
310 ATELECTASIS 92 0.0095
311 PARESIS 21 0.0094
312 HEPATIC CYST 32 0.0094
313 RETINOPATHY 35 0.0094
314 BACTERIAL INFECTION 175 0.0094
315 LUNG CONSOLIDATION 26 0.0093
316 MUCORMYCOSIS 24 0.0092
317 BASAL CELL CARCINOMA 144 0.0092
318 NEUTROPENIA 1244 0.0091
319 PURULENT DISCHARGE 39 0.0091
320 TOOTH EXTRACTION 112 0.0090
321 HYPERAMMONAEMIA 45 0.0090
322 BONE MARROW TRANSPLANT 17 0.0090
323 PULMONARY ALVEOLAR HAEMORRHAGE 50 0.0089
324 RENAL TUBULAR DISORDER 25 0.0089
325 PATHOLOGICAL FRACTURE 45 0.0089
326 COMPUTERISED TOMOGRAM ABNORMAL 20 0.0088
327 BONE DISORDER 159 0.0087
328 RETINITIS 15 0.0087
329 VENOUS THROMBOSIS 34 0.0087
330 LOBAR PNEUMONIA 16 0.0086
331 LUNG ADENOCARCINOMA 26 0.0086
332 HERPES SIMPLEX 56 0.0086
333 PSEUDOMEMBRANOUS COLITIS 19 0.0085
334 IMMUNE THROMBOCYTOPENIC PURPURA 24 0.0085
335 INVASIVE DUCTAL BREAST CARCINOMA 23 0.0085
336 RESPIRATORY SYNCYTIAL VIRUS INFECTION 73 0.0084
337 HYPOREFLEXIA 16 0.0083
338 BRAIN ABSCESS 21 0.0083
339 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 22 0.0083
340 HYPERBILIRUBINAEMIA 85 0.0082
341 PNEUMONIA KLEBSIELLA 15 0.0082
342 SEPSIS 908 0.0081
343 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 31 0.0081
344 OPPORTUNISTIC INFECTION 15 0.0081
345 PNEUMOCYSTIS JIROVECI PNEUMONIA 18 0.0081
346 ILEUS PARALYTIC 36 0.0081
347 RETINAL HAEMORRHAGE 57 0.0080
348 SMALL INTESTINAL PERFORATION 15 0.0080
349 CANDIDIASIS 32 0.0080
350 BONE MARROW DISORDER 24 0.0079
351 NEUROPATHY PERIPHERAL 755 0.0079
352 OSTEONECROSIS 260 0.0079
353 PNEUMONIA VIRAL 25 0.0078
354 RENAL CELL CARCINOMA 38 0.0078
355 ATROPHY 15 0.0077
356 CYTOKINE RELEASE SYNDROME 154 0.0077
357 ORAL FUNGAL INFECTION 21 0.0077
358 ISCHAEMIA 35 0.0076
359 DEAFNESS NEUROSENSORY 25 0.0076
360 OESOPHAGITIS 83 0.0076
361 AUTONOMIC NERVOUS SYSTEM IMBALANCE 22 0.0075
362 MYOSITIS 67 0.0075
363 HEPATITIS FULMINANT 22 0.0074
364 SPINAL OSTEOARTHRITIS 65 0.0074
365 OSTEONECROSIS OF JAW 182 0.0073
366 LEFT VENTRICULAR DYSFUNCTION 49 0.0073
367 ORGANISING PNEUMONIA 36 0.0073
368 HEPATOMEGALY 71 0.0072
369 RADICULOPATHY 19 0.0072
370 HYPERCALCAEMIA 89 0.0072
371 DUODENITIS 22 0.0072
372 CANDIDA INFECTION 121 0.0072
373 MYELOSUPPRESSION 258 0.0072
374 CARDIOMYOPATHY 105 0.0071
375 HYPERVOLAEMIA 35 0.0071
376 OSTEOMYELITIS 128 0.0071
377 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 35 0.0070
378 NECROSIS 39 0.0070
379 DISEASE PROGRESSION 827 0.0070
380 EXOPHTHALMOS 15 0.0070
381 CHRONIC MYELOID LEUKAEMIA 32 0.0069
382 PERIODONTITIS 15 0.0069
383 SKIN TOXICITY 39 0.0069
384 PERICARDIAL EFFUSION 159 0.0069
385 NEUROTOXICITY 120 0.0068
386 ESCHERICHIA URINARY TRACT INFECTION 29 0.0068
387 BRAIN NATRIURETIC PEPTIDE INCREASED 21 0.0068
388 MULTIPLE-DRUG RESISTANCE 21 0.0068
389 BLOOD LACTATE DEHYDROGENASE INCREASED 107 0.0067
390 RETINAL DETACHMENT 62 0.0067
391 GASTROINTESTINAL INJURY 18 0.0067
392 HYPOALBUMINAEMIA 52 0.0067
393 HAEMATOLOGICAL MALIGNANCY 19 0.0067
394 HYPOPHOSPHATAEMIA 49 0.0066
395 AORTIC VALVE INCOMPETENCE 28 0.0066
396 VENTRICULAR DYSFUNCTION 17 0.0065
397 ACTINIC KERATOSIS 17 0.0065
398 CARDIAC TAMPONADE 31 0.0065
399 GASTROINTESTINAL NECROSIS 19 0.0065
400 GROWTH RETARDATION 19 0.0064
401 APLASIA PURE RED CELL 22 0.0064
402 RECURRENT CANCER 26 0.0064
403 ORAL DISORDER 46 0.0063
404 FAILURE TO THRIVE 32 0.0062
405 RESPIRATORY FAILURE 449 0.0062
406 HEPATOTOXICITY 136 0.0061
407 HAEMODYNAMIC INSTABILITY 46 0.0060
408 COVID-19 PNEUMONIA 71 0.0060
409 LYMPHOMA 92 0.0059
410 LEUKAEMIA 56 0.0059
411 ENCEPHALOPATHY 145 0.0059
412 HAEMORRHAGE URINARY TRACT 15 0.0059
413 METASTASIS 42 0.0059
414 PNEUMONITIS 159 0.0058
415 LEUKOPENIA 290 0.0058
416 VASCULAR DEVICE INFECTION 26 0.0057
417 CARDIAC FAILURE ACUTE 38 0.0057
418 BRONCHIOLITIS 20 0.0057
419 ACUTE RESPIRATORY FAILURE 109 0.0057
420 PNEUMONIA BACTERIAL 52 0.0057
421 METABOLIC ENCEPHALOPATHY 17 0.0057
422 OESOPHAGEAL STENOSIS 16 0.0056
423 EYELID PTOSIS 57 0.0056
424 COMPRESSION FRACTURE 30 0.0056
425 HYPERURICAEMIA 23 0.0056
426 PULMONARY HYPERTENSION 116 0.0056
427 PAPILLOEDEMA 25 0.0055
428 SUSPECTED OFF LABEL USE 25 0.0055
429 CARDIOMEGALY 68 0.0055
430 DRUG RESISTANCE 142 0.0055
431 ATRIAL FLUTTER 44 0.0055
432 COLITIS 209 0.0055
433 DRUG TOXICITY 75 0.0055
434 TRANSPLANT REJECTION 44 0.0055
435 CLONUS 15 0.0055
436 STOMATITIS 332 0.0055
437 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 56 0.0054
438 EYELID OEDEMA 63 0.0054
439 EMBOLISM 45 0.0054
440 NEPHROTIC SYNDROME 37 0.0054
441 HERPES VIRUS INFECTION 31 0.0054
442 PATHOGEN RESISTANCE 49 0.0054
443 MALIGNANT MELANOMA 72 0.0054
444 INFECTION 774 0.0053
445 LOOSE TOOTH 17 0.0053
446 FIBROSIS 16 0.0052
447 HYPOXIA 183 0.0052
448 ILEUS 63 0.0051
449 DISEASE RECURRENCE 241 0.0051
450 HERPES ZOSTER 290 0.0050
451 BRONCHOPNEUMONIA 17 0.0050
452 RESPIRATORY TRACT INFECTION 129 0.0049
453 RENAL FAILURE CHRONIC 38 0.0049
454 PLEURAL EFFUSION 298 0.0049
455 ARTHRITIS BACTERIAL 20 0.0049
456 DEVICE RELATED INFECTION 75 0.0049
457 MITRAL VALVE INCOMPETENCE 55 0.0049
458 RESPIRATORY DISTRESS 134 0.0049
459 OLIGURIA 30 0.0048
460 ANGIOPATHY 27 0.0048
461 SQUAMOUS CELL CARCINOMA 45 0.0048
462 ASCITES 139 0.0047
463 HAEMOLYTIC ANAEMIA 42 0.0047
464 CEREBRAL ISCHAEMIA 24 0.0047
465 HEPATIC LESION 20 0.0046
466 IMMUNE-MEDIATED ENTEROCOLITIS 17 0.0046
467 SPINAL CORD COMPRESSION 18 0.0046
468 FLUID OVERLOAD 67 0.0046
469 SPINAL COMPRESSION FRACTURE 38 0.0046
470 PULSELESS ELECTRICAL ACTIVITY 19 0.0045
471 DECUBITUS ULCER 37 0.0045
472 TOXIC ENCEPHALOPATHY 23 0.0045
473 TRICUSPID VALVE INCOMPETENCE 36 0.0045
474 GINGIVAL SWELLING 20 0.0045
475 TOOTH ABSCESS 46 0.0045
476 STREPTOCOCCAL INFECTION 25 0.0045
477 ENDOCARDITIS 23 0.0045
478 HYPOVOLAEMIA 26 0.0044
479 PERIORBITAL OEDEMA 23 0.0044
480 PULMONARY ARTERIAL HYPERTENSION 64 0.0044
481 HYPERNATRAEMIA 22 0.0044
482 HAEMODIALYSIS 37 0.0044
483 JAW DISORDER 24 0.0044
484 TOXIC SKIN ERUPTION 44 0.0044
485 FUNGAL INFECTION 145 0.0043
486 GUILLAIN-BARRE SYNDROME 21 0.0043
487 GRANULOMA 15 0.0043
488 CEREBRAL ATROPHY 17 0.0043
489 NO THERAPEUTIC RESPONSE 52 0.0043
490 DEEP VEIN THROMBOSIS 276 0.0042
491 NEUTROPHIL COUNT DECREASED 172 0.0042
492 LEFT VENTRICULAR HYPERTROPHY 18 0.0042
493 DISSEMINATED INTRAVASCULAR COAGULATION 59 0.0042
494 BLOOD BILIRUBIN INCREASED 113 0.0042
495 RENAL CYST 33 0.0042
496 RENAL FAILURE ACUTE 176 0.0041
497 ADRENAL INSUFFICIENCY 50 0.0041
498 INTERVERTEBRAL DISC DEGENERATION 38 0.0041
499 STAPHYLOCOCCAL INFECTION 134 0.0041
500 LUNG INFECTION 63 0.0041
501 HEPATIC FAILURE 122 0.0040
502 SPINAL COLUMN STENOSIS 19 0.0040
503 PARTIAL SEIZURES 21 0.0040
504 PNEUMOTHORAX 63 0.0040
505 IMMUNOSUPPRESSION 35 0.0040
506 METABOLIC DISORDER 23 0.0040
507 ANAEMIA 751 0.0039
508 EJECTION FRACTION DECREASED 61 0.0039
509 PRODUCT USE IN UNAPPROVED INDICATION 967 0.0039
510 GINGIVITIS 21 0.0039
511 DIVERTICULUM INTESTINAL 17 0.0039
512 HYPERTRANSAMINASAEMIA 27 0.0039
513 ACUTE KIDNEY INJURY 592 0.0039
514 BRONCHIECTASIS 26 0.0039
515 NEOPLASM PROGRESSION 134 0.0038
516 TACHYPNOEA 52 0.0038
517 EXERCISE TOLERANCE DECREASED 22 0.0038
518 INTESTINAL ISCHAEMIA 21 0.0038
519 DERMATITIS EXFOLIATIVE 19 0.0038
520 PULMONARY OEDEMA 170 0.0038
521 CARDIAC FAILURE 301 0.0037
522 TOXICITY TO VARIOUS AGENTS 632 0.0037
523 MENINGITIS 25 0.0037
524 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 22 0.0037
525 ODYNOPHAGIA 22 0.0037
526 RENAL FAILURE 489 0.0037
527 CLOSTRIDIUM DIFFICILE INFECTION 80 0.0037
528 DIVERTICULUM 26 0.0037
529 SERUM FERRITIN INCREASED 19 0.0036
530 PNEUMONIA 1163 0.0036
531 INTESTINAL PERFORATION 40 0.0036
532 ACUTE PULMONARY OEDEMA 20 0.0036
533 AGRANULOCYTOSIS 66 0.0035
534 INTENTIONAL PRODUCT USE ISSUE 311 0.0035
535 STATUS EPILEPTICUS 40 0.0035
536 BLOOD ALBUMIN DECREASED 28 0.0035
537 INTERVERTEBRAL DISC DISORDER 15 0.0035
538 LUNG NEOPLASM 15 0.0035
539 CACHEXIA 18 0.0035
540 GASTROENTERITIS 51 0.0035
541 GENERALISED OEDEMA 43 0.0035
542 MYOPATHY 30 0.0035
543 PYREXIA 1186 0.0034
544 TRANSAMINASES INCREASED 76 0.0034
545 PHYSICAL DISABILITY 15 0.0034
546 HAEMOLYSIS 26 0.0034
547 COAGULOPATHY 56 0.0034
548 PULMONARY CONGESTION 44 0.0033
549 PAIN IN JAW 94 0.0033
550 RENAL IMPAIRMENT 278 0.0033
551 TUBULOINTERSTITIAL NEPHRITIS 62 0.0033
552 LYMPHADENOPATHY 117 0.0033
553 HYPOKALAEMIA 152 0.0033
554 GASTROINTESTINAL INFECTION 29 0.0032
555 OSTEOPENIA 49 0.0032
556 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 177 0.0032
557 MALNUTRITION 36 0.0032
558 ECCHYMOSIS 22 0.0032
559 PROTHROMBIN TIME PROLONGED 19 0.0032
560 EXOSTOSIS 29 0.0032
561 ARTERIOSCLEROSIS CORONARY ARTERY 21 0.0032
562 VIRAL INFECTION 105 0.0032
563 BRONCHOSPASM 45 0.0032
564 NEUROLOGICAL SYMPTOM 18 0.0031
565 MENTAL STATUS CHANGES 87 0.0031
566 RIB FRACTURE 64 0.0031
567 ATRIAL FIBRILLATION 302 0.0031
568 ACUTE HEPATIC FAILURE 42 0.0031
569 HYPOCALCAEMIA 58 0.0031
570 ELECTROLYTE IMBALANCE 35 0.0030
571 BLOOD DISORDER 24 0.0030
572 INTERSTITIAL LUNG DISEASE 145 0.0030
573 DENTAL CARIES 33 0.0030
574 PLATELET COUNT DECREASED 313 0.0029
575 MASS 41 0.0029
576 GLOMERULAR FILTRATION RATE DECREASED 36 0.0029
577 ORTHOSTATIC HYPOTENSION 51 0.0029
578 PARANOIA 50 0.0029
579 OFF LABEL USE 2533 0.0029
580 PYELONEPHRITIS 25 0.0029
581 EMPHYSEMA 29 0.0029
582 ATAXIA 34 0.0029
583 IMPAIRED HEALING 94 0.0029
584 CARDIOGENIC SHOCK 41 0.0029
585 GRANULOCYTOPENIA 16 0.0028
586 IMMUNE SYSTEM DISORDER 37 0.0028
587 MALIGNANT NEOPLASM PROGRESSION 287 0.0028
588 ANURIA 24 0.0028
589 DEFORMITY 26 0.0028
590 ACUTE CORONARY SYNDROME 23 0.0028
591 LUNG DISORDER 136 0.0028
592 PULMONARY FIBROSIS 53 0.0028
593 JOINT EFFUSION 19 0.0028
594 NERVOUS SYSTEM DISORDER 86 0.0028
595 HAEMORRHAGE INTRACRANIAL 41 0.0027
596 LARGE INTESTINE PERFORATION 19 0.0027
597 DECREASED INTEREST 16 0.0027
598 RIGHT VENTRICULAR FAILURE 19 0.0027
599 RASH MACULO-PAPULAR 60 0.0027
600 NEOPLASM 31 0.0027
601 PROTEINURIA 51 0.0027
602 APPENDICITIS 25 0.0027
603 SPLENOMEGALY 31 0.0026
604 SUDDEN DEATH 28 0.0026
605 ABSCESS 42 0.0026
606 PULMONARY MASS 39 0.0026
607 HEPATITIS ACUTE 17 0.0026
608 SUPRAVENTRICULAR TACHYCARDIA 25 0.0026
609 CHOLESTASIS 50 0.0026
610 SCOLIOSIS 16 0.0026
611 NEPHROPATHY 24 0.0026
612 HYPERGLYCAEMIA 93 0.0025
613 CHOLECYSTITIS 30 0.0025
614 GINGIVAL PAIN 20 0.0025
615 METASTASES TO LUNG 29 0.0025
616 TOXIC EPIDERMAL NECROLYSIS 38 0.0025
617 PHARYNGITIS 31 0.0025
618 DRUG ERUPTION 44 0.0025
619 BRAIN OEDEMA 31 0.0025
620 RENAL TUBULAR NECROSIS 24 0.0024
621 HYPOMAGNESAEMIA 34 0.0024
622 CEREBRAL DISORDER 18 0.0024
623 ORAL CANDIDIASIS 32 0.0024
624 UPPER RESPIRATORY TRACT INFECTION 112 0.0024
625 PULMONARY EMBOLISM 229 0.0024
626 SINUS TACHYCARDIA 34 0.0024
627 HEPATITIS 61 0.0024
628 GENERAL PHYSICAL CONDITION ABNORMAL 16 0.0024
629 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 40 0.0023
630 HEPATITIS C 28 0.0023
631 MOUTH HAEMORRHAGE 17 0.0023
632 METASTASES TO BONE 38 0.0023
633 LYMPHOEDEMA 16 0.0023
634 THERAPY NON-RESPONDER 104 0.0023
635 CEREBRAL HAEMORRHAGE 82 0.0023
636 SMALL INTESTINAL OBSTRUCTION 28 0.0023
637 HYPONATRAEMIA 128 0.0023
638 BLOOD UREA INCREASED 38 0.0023
639 HIATUS HERNIA 29 0.0022
640 ARTERIOSCLEROSIS 21 0.0022
641 VENTRICULAR EXTRASYSTOLES 23 0.0022
642 TENDERNESS 23 0.0022
643 CELLULITIS 110 0.0022
644 SINUS BRADYCARDIA 21 0.0022
645 ALTERED STATE OF CONSCIOUSNESS 47 0.0022
646 HAEMATOCRIT DECREASED 43 0.0022
647 NEURALGIA 52 0.0021
648 END STAGE RENAL DISEASE 39 0.0021
649 BLOOD CREATININE INCREASED 139 0.0021
650 GASTRITIS 56 0.0021
651 OEDEMA 115 0.0021
652 JAUNDICE 57 0.0021
653 DIALYSIS 30 0.0021
654 GASTROINTESTINAL HAEMORRHAGE 176 0.0021
655 DEAFNESS 55 0.0021
656 HAEMATURIA 72 0.0021
657 HYPERTHERMIA 16 0.0021
658 HYPERLIPIDAEMIA 25 0.0021
659 MOUTH ULCERATION 44 0.0021
660 ASPARTATE AMINOTRANSFERASE INCREASED 110 0.0021
661 LIVER DISORDER 91 0.0020
662 HAEMORRHAGIC STROKE 16 0.0020
663 PNEUMONIA ASPIRATION 51 0.0020
664 PURPURA 18 0.0020
665 DIARRHOEA HAEMORRHAGIC 19 0.0020
666 PETECHIAE 21 0.0020
667 GENERAL PHYSICAL HEALTH DETERIORATION 231 0.0020
668 SUBARACHNOID HAEMORRHAGE 20 0.0020
669 ACIDOSIS 15 0.0020
670 FISTULA 22 0.0020
671 HEPATIC FUNCTION ABNORMAL 73 0.0020
672 HAEMORRHOIDS 38 0.0019
673 ANOREXIA 25 0.0019
674 INTERVERTEBRAL DISC PROTRUSION 42 0.0019
675 TOOTH INFECTION 25 0.0019
676 TACHYCARDIA 168 0.0019
677 SUBDURAL HAEMATOMA 27 0.0019
678 LEUKOCYTOSIS 34 0.0019
679 DISORIENTATION 74 0.0019
680 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 132 0.0019
681 ACUTE MYOCARDIAL INFARCTION 54 0.0018
682 MELAENA 40 0.0018
683 TOOTH FRACTURE 20 0.0018
684 TRANSFUSION 19 0.0018
685 SPINAL DISORDER 17 0.0018
686 C-REACTIVE PROTEIN INCREASED 65 0.0018
687 METASTASES TO CENTRAL NERVOUS SYSTEM 23 0.0018
688 BONE PAIN 104 0.0018
689 MYOCARDIAL ISCHAEMIA 20 0.0018
690 ORAL PAIN 39 0.0017
691 HYPERKALAEMIA 61 0.0017
692 PANCREATITIS ACUTE 39 0.0017
693 ARRHYTHMIA 82 0.0017
694 DELIRIUM 60 0.0017
695 HYPOTENSION 346 0.0017
696 HYPOPHAGIA 44 0.0017
697 WHITE BLOOD CELL COUNT DECREASED 186 0.0017
698 HEPATIC ENCEPHALOPATHY 16 0.0017
699 OEDEMA PERIPHERAL 208 0.0017
700 VENTRICULAR TACHYCARDIA 28 0.0017
701 UNEVALUABLE EVENT 127 0.0017
702 DIARRHOEA 1080 0.0017
703 HAEMOGLOBIN DECREASED 171 0.0017
704 MYOCARDITIS 19 0.0017
705 PRODUCT USE ISSUE 311 0.0017
706 OPTIC NEURITIS 15 0.0016
707 BURSITIS 20 0.0016
708 ALANINE AMINOTRANSFERASE INCREASED 101 0.0016
709 DERMATITIS 34 0.0016
710 SHOCK 37 0.0016
711 GASTROINTESTINAL DISORDER 144 0.0016
712 FACE OEDEMA 27 0.0016
713 METASTASES TO LIVER 28 0.0016
714 CARDIAC FAILURE CONGESTIVE 127 0.0016
715 HAEMATEMESIS 40 0.0016
716 SCAR 27 0.0016
717 HYPERTENSION 331 0.0016
718 HYPERCHOLESTEROLAEMIA 15 0.0016
719 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
720 TOOTH LOSS 32 0.0015
721 RESPIRATORY DISORDER 46 0.0015
722 SKIN LESION 42 0.0015
723 CIRCULATORY COLLAPSE 26 0.0015
724 RENAL DISORDER 71 0.0015
725 DEPRESSED LEVEL OF CONSCIOUSNESS 60 0.0015
726 CARDIAC ARREST 125 0.0015
727 MYOCLONUS 18 0.0015
728 THYROID CANCER 18 0.0015
729 LOWER RESPIRATORY TRACT INFECTION 68 0.0015
730 DYSURIA 55 0.0015
731 TOOTHACHE 27 0.0015
732 STEVENS-JOHNSON SYNDROME 33 0.0015
733 DIVERTICULITIS 41 0.0015
734 TREATMENT FAILURE 121 0.0015
735 VASCULITIS 17 0.0015
736 GLAUCOMA 28 0.0015
737 GENERALISED TONIC-CLONIC SEIZURE 24 0.0014
738 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32 0.0014
739 LIVER FUNCTION TEST INCREASED 31 0.0014
740 TOOTH DISORDER 32 0.0014
741 SKIN INFECTION 16 0.0014
742 BLOOD CALCIUM DECREASED 16 0.0014
743 MUSCULOSKELETAL CHEST PAIN 22 0.0014
744 CARDIOVASCULAR DISORDER 36 0.0014
745 OSTEOPOROSIS 58 0.0014
746 BLOOD ALKALINE PHOSPHATASE INCREASED 35 0.0014
747 SKIN DISORDER 47 0.0014
748 DYSPNOEA EXERTIONAL 53 0.0014
749 ISCHAEMIC STROKE 25 0.0014
750 CATARACT 83 0.0014
751 OSTEOARTHRITIS 59 0.0014
752 LIVER INJURY 34 0.0014
753 ULCER 22 0.0014
754 URINARY RETENTION 46 0.0014
755 BRADYCARDIA 73 0.0014
756 ASPIRATION 15 0.0014
757 PERICARDITIS 23 0.0014
758 ABNORMAL BEHAVIOUR 54 0.0014
759 CEREBRAL INFARCTION 33 0.0013
760 DEHYDRATION 180 0.0013
761 CONVULSION 77 0.0013
762 EPILEPSY 41 0.0013
763 ANHEDONIA 35 0.0013
764 RED BLOOD CELL COUNT DECREASED 38 0.0013
765 INTESTINAL OBSTRUCTION 50 0.0013
766 HYPOTHYROIDISM 42 0.0013
767 PERITONITIS 27 0.0013
768 THERAPEUTIC RESPONSE DECREASED 79 0.0013
769 GASTRIC CANCER 33 0.0013
770 LYMPHOCYTE COUNT DECREASED 23 0.0013
771 EPISTAXIS 97 0.0013
772 THROMBOSIS 104 0.0013
773 POST PROCEDURAL HAEMORRHAGE 15 0.0013
774 HEPATIC STEATOSIS 24 0.0013
775 BRONCHITIS 95 0.0013
776 ORAL HERPES 25 0.0013
777 COLON CANCER 19 0.0013
778 HAEMOPTYSIS 35 0.0013
779 INFUSION RELATED REACTION 83 0.0013
780 GINGIVAL BLEEDING 17 0.0012
781 CONFUSIONAL STATE 201 0.0012
782 CYSTITIS 39 0.0012
783 SKIN REACTION 17 0.0012
784 CONJUNCTIVITIS 22 0.0012
785 MUSCLE ATROPHY 15 0.0012
786 HEMIPARESIS 20 0.0012
787 BODY TEMPERATURE INCREASED 24 0.0012
788 INFLAMMATION 60 0.0012
789 URINARY TRACT INFECTION 198 0.0012
790 CHOLELITHIASIS 38 0.0012
791 COVID-19 202 0.0012
792 DRUG INEFFECTIVE 1496 0.0011
793 METABOLIC ACIDOSIS 36 0.0011
794 PARALYSIS 16 0.0011
795 MUSCULAR WEAKNESS 125 0.0011
796 SYNCOPE 110 0.0011
797 TRANSIENT ISCHAEMIC ATTACK 37 0.0011
798 HAEMORRHAGE 114 0.0011
799 CORONARY ARTERY DISEASE 33 0.0011
800 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 28 0.0011
801 DRUG-INDUCED LIVER INJURY 34 0.0011
802 PRESYNCOPE 26 0.0011
803 FRACTURE 20 0.0011
804 VISUAL ACUITY REDUCED 35 0.0011
805 DYSPHAGIA 100 0.0011
806 INJURY 74 0.0011
807 CARDIO-RESPIRATORY ARREST 44 0.0011
808 ANAPHYLACTIC SHOCK 27 0.0010
809 FULL BLOOD COUNT DECREASED 21 0.0010
810 POST PROCEDURAL COMPLICATION 20 0.0010
811 DRUG INTOLERANCE 100 0.0010
812 AGITATION 76 0.0010
813 RECTAL HAEMORRHAGE 44 0.0010
814 EAR INFECTION 27 0.0010
815 VOMITING 477 0.0010
816 DECREASED APPETITE 232 0.0010
817 APHASIA 30 0.0010
818 DRUG EFFECT INCOMPLETE 36 0.0010
819 CONSTIPATION 214 0.0010
820 AMENORRHOEA 17 0.0010
821 HAEMATOMA 25 0.0010
822 HALLUCINATION 72 0.0010
823 MUSCULOSKELETAL PAIN 50 0.0010
824 CARDIAC DISORDER 89 0.0010
825 CHRONIC KIDNEY DISEASE 72 0.0009
826 PRODUCTIVE COUGH 45 0.0009
827 GASTROENTERITIS VIRAL 17 0.0009
828 RASH ERYTHEMATOUS 45 0.0009
829 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 49 0.0009
830 FEMUR FRACTURE 29 0.0009
831 POLLAKIURIA 39 0.0009
832 INFLUENZA 104 0.0009
833 SKIN ULCER 24 0.0009
834 LOCAL SWELLING 16 0.0009
835 URINARY INCONTINENCE 27 0.0009
836 ABDOMINAL PAIN 212 0.0009
837 SINUS DISORDER 18 0.0009
838 RASH 395 0.0009
839 CHILLS 106 0.0009
840 COMA 43 0.0009
841 NIGHT SWEATS 29 0.0009
842 WOUND 25 0.0009
843 NEOPLASM MALIGNANT 59 0.0009
844 BLINDNESS 36 0.0009
845 HYPOAESTHESIA 132 0.0009
846 PANCREATITIS 46 0.0009
847 DIABETES MELLITUS 66 0.0009
848 SINUSITIS 88 0.0009
849 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20 0.0009
850 UNRESPONSIVE TO STIMULI 22 0.0009
851 LETHARGY 49 0.0009
852 DIPLOPIA 22 0.0008
853 DEATH 729 0.0008
854 FLUID RETENTION 43 0.0008
855 COUGH 237 0.0008
856 FOOT FRACTURE 16 0.0008
857 ANGINA PECTORIS 24 0.0008
858 GOUT 15 0.0008
859 PRODUCT PRESCRIBING ISSUE 18 0.0008
860 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 24 0.0008
861 DISABILITY 16 0.0008
862 ASTHENIA 303 0.0008
863 OXYGEN SATURATION DECREASED 45 0.0008
864 DISTURBANCE IN ATTENTION 43 0.0008
865 DYSPNOEA 450 0.0008
866 LACTIC ACIDOSIS 25 0.0008
867 EAR PAIN 15 0.0008
868 BLOOD POTASSIUM DECREASED 23 0.0008
869 ERYTHEMA 157 0.0008
870 NAUSEA 603 0.0008
871 DEMENTIA 21 0.0008
872 SWELLING 70 0.0007
873 SKIN CANCER 16 0.0007
874 RENAL INJURY 22 0.0007
875 CONDITION AGGRAVATED 216 0.0007
876 SEIZURE 81 0.0007
877 ERECTILE DYSFUNCTION 18 0.0007
878 PROSTATE CANCER 56 0.0007
879 ADVERSE EVENT 64 0.0007
880 LIVER FUNCTION TEST ABNORMAL 20 0.0007
881 HIP FRACTURE 22 0.0007
882 BACK PAIN 158 0.0007
883 HAEMATOCHEZIA 37 0.0007
884 PARAESTHESIA 105 0.0007
885 ILL-DEFINED DISORDER 40 0.0007
886 ABDOMINAL DISTENSION 67 0.0006
887 WEIGHT DECREASED 179 0.0006
888 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
889 HEPATIC ENZYME INCREASED 43 0.0006
890 MEDICATION ERROR 35 0.0006
891 EMOTIONAL DISTRESS 76 0.0006
892 INTENTIONAL PRODUCT MISUSE 54 0.0006
893 RESPIRATORY ARREST 17 0.0006
894 HYPOGLYCAEMIA 29 0.0006
895 GASTROOESOPHAGEAL REFLUX DISEASE 48 0.0006
896 FATIGUE 462 0.0006
897 LUNG NEOPLASM MALIGNANT 24 0.0006
898 HYPOACUSIS 25 0.0006
899 ARTHROPATHY 32 0.0006
900 TINNITUS 26 0.0006
901 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
902 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
903 DRUG INTERACTION 88 0.0006
904 WHITE BLOOD CELL COUNT INCREASED 21 0.0005
905 ARTHRITIS 43 0.0005
906 DISCOMFORT 33 0.0005
907 WHEEZING 32 0.0005
908 OROPHARYNGEAL PAIN 49 0.0005
909 BLISTER 28 0.0005
910 COGNITIVE DISORDER 23 0.0005
911 ANAPHYLACTIC REACTION 27 0.0005
912 CHEST PAIN 89 0.0005
913 DYSARTHRIA 18 0.0005
914 AMNESIA 31 0.0005
915 FALL 156 0.0005
916 TREMOR 77 0.0005
917 NEPHROLITHIASIS 21 0.0005
918 PAIN 281 0.0005
919 GAIT DISTURBANCE 87 0.0005
920 MYOCARDIAL INFARCTION 78 0.0004
921 BREAST CANCER 41 0.0004
922 ANXIETY 123 0.0004
923 NECK PAIN 24 0.0004
924 RASH MACULAR 15 0.0004
925 WEIGHT INCREASED 96 0.0004
926 TREATMENT NONCOMPLIANCE 23 0.0004
927 CEREBROVASCULAR ACCIDENT 71 0.0004
928 DYSPEPSIA 41 0.0004
929 CONTUSION 40 0.0004
930 MENTAL DISORDER 18 0.0004
931 PAIN IN EXTREMITY 121 0.0004
932 DRUG ABUSE 34 0.0004
933 RHABDOMYOLYSIS 17 0.0004
934 BLOOD PRESSURE DECREASED 27 0.0004
935 SKIN EXFOLIATION 34 0.0004
936 NASAL CONGESTION 23 0.0004
937 DYSGEUSIA 29 0.0004
938 SOMNOLENCE 77 0.0004
939 DRY EYE 19 0.0004
940 ADVERSE DRUG REACTION 34 0.0004
941 MULTIPLE SCLEROSIS 18 0.0004
942 DEPRESSION 84 0.0004
943 DRY MOUTH 29 0.0004
944 BLADDER CANCER 21 0.0004
945 RHINORRHOEA 23 0.0004
946 HYPERSENSITIVITY 66 0.0004
947 HEART RATE INCREASED 35 0.0004
948 SWELLING FACE 23 0.0004
949 LOSS OF CONSCIOUSNESS 45 0.0004
950 INSOMNIA 93 0.0003
951 MOBILITY DECREASED 25 0.0003
952 VISION BLURRED 47 0.0003
953 OCULAR HYPERAEMIA 16 0.0003
954 DIZZINESS 166 0.0003
955 CHEST DISCOMFORT 33 0.0003
956 VERTIGO 19 0.0003
957 ABDOMINAL PAIN UPPER 63 0.0003
958 MYALGIA 51 0.0003
959 MUSCLE SPASMS 55 0.0003
960 VISUAL IMPAIRMENT 37 0.0003
961 RASH PRURITIC 16 0.0003
962 SUICIDAL IDEATION 27 0.0003
963 ARTHRALGIA 118 0.0003
964 DYSPHONIA 16 0.0003
965 SLEEP DISORDER 19 0.0003
966 DRY SKIN 35 0.0003
967 INJECTION SITE REACTION 18 0.0003
968 ALOPECIA 46 0.0002
969 PRURITUS 90 0.0002
970 HEADACHE 139 0.0002
971 INFLUENZA LIKE ILLNESS 18 0.0002
972 FLUSHING 22 0.0002
973 JOINT SWELLING 26 0.0002
974 BURNING SENSATION 15 0.0002
975 BLOOD PRESSURE INCREASED 32 0.0002
976 MEMORY IMPAIRMENT 26 0.0002
977 NO ADVERSE EVENT 34 0.0002
978 ASTHMA 20 0.0002
979 ABDOMINAL DISCOMFORT 29 0.0002
980 HYPERHIDROSIS 22 0.0002
981 HOSPITALISATION 26 0.0002
982 MALAISE 71 0.0002
983 BLOOD GLUCOSE INCREASED 30 0.0002
984 URTICARIA 26 0.0002
985 PALPITATIONS 18 0.0002
986 PSORIASIS 20 0.0002
987 PERIPHERAL SWELLING 23 0.0001
988 NASOPHARYNGITIS 24 0.0001
989 INJECTION SITE ERYTHEMA 16 0.0001
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
991 OVERDOSE 18 0.0001